Colonisation of fluoroquinolone-resistant Haemophilus influenzae among nursing home residents in southern Taiwan

Journal of Hospital Infection

Volumn 75, Issue 4, 2010, Pages 304-308

  Chang, C M ^a,b   Lauderdale, T L ^c   Lee, H C ^a,b   Lee, N Y ^a,b   Wu, C J ^a,b   Chen, P L ^a,b   Lee, C C ^a,b   Chen, P C ^c   Ko, W C ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Fluoroquinolone; Haemophilus influenzae; Nursing home; Resistance

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; BETA LACTAMASE; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; COTRIMOXAZOLE; ERTAPENEM; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SULTAMICILLIN; HETEROCYCLIC COMPOUND; OFLOXACIN; QUINOLINE DERIVATIVE; QUINOLONE DERIVATIVE;

AGED; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL COLONIZATION; CLINICAL ARTICLE; FEMALE; HAEMOPHILUS INFLUENZAE; HUMAN; MALE; NURSING HOME PATIENT; PULSED FIELD GEL ELECTROPHORESIS; SEROTYPE; TAIWAN; BACTERIAL COUNT; CLASSIFICATION; DRUG EFFECTS; ISOLATION AND PURIFICATION; NURSING HOME; PROSPECTIVE STUDY; RISK FACTOR; SEROTYPING;

AGED; AZA COMPOUNDS; BETA-LACTAMASES; COLONY COUNT, MICROBIAL; DRUG RESISTANCE, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; MALE; NURSING HOMES; OFLOXACIN; PROSPECTIVE STUDIES; QUINOLINES; RISK FACTORS; SEROTYPING; TAIWAN; FLUOROQUINOLONES; LEVOFLOXACIN;

EID: 77954534771     PISSN: 01956701     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.12.020     Document Type: Article

References (28)

1. Murphy T.F. Haemophilus infections. Mandell, Douglas, and Benett's principles and practice of infectious diseases 2005, 2661-2669. Churchill Livingstone, New York. 6th ed. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
2. Goldstein I.J.C., Garabedian-Ruffalo S.M. Widespread use of fluoroquinolones versus emerging resistance in pneumococci. Clin Infect Dis 2002, 35:1505-1511.
3. Barriere S.L., Hindler J.A. Ciprofloxacin-resistant Haemophilus influenzae infection in a patient with chronic lung disease. Ann Pharmacother 1993, 27:309-310.
4. Inoue M., Lee N.Y., Hong S.W., Lee K., Felmingham D. PROTEKT 1999-2000: a multicentre study of the antibiotic susceptibility of respiratory tract pathogens in Hong Kong, Japan and South Korea. Int J Antimicrob Agents 2004, 23:44-51.
5. Biedenbach D.J., Jones R.N. Five-year analysis of Haemophilus influenzae isolates with reduced susceptibility to fluoroquinolones: prevalence results from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2003, 46:55-61.
6. Jacobs M.R., Felmingham D., Appelbaum P.C., Grüneberg R.N. The Alexander Project 1998-2000: susceptibility of pathogens isolated from community-acquired respiratory tract infection to commonly used antimicrobial agents. J Antimicrob Chemother 2003, 52:229-246. the Alexander Project Group.
7. Brown S.D., Rybak M.J. Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study. J Antimicrob Chemother 2004, 54(Suppl. S1):i7-i15.
8. Yokota S., Ohkoshi Y., Sato K., Fujii N. Emergence of fluoroquinolone-resistant Haemophilus influenzae strains among elderly patients but not among children. J Clin Microbiol 2008, 46:361-365.
9. Campos J., Sáez-Nieto J.A. Gram negative infections: Haemophilus and other clinically relevant Gram negative coccobacilli. Laboratory diagnosis of bacterial infections 2001, 557-580. Dekker, New York. N. Cimolai (Ed.).
10. Bootsma H.G., Troelstra A., van Veen-Rutgers A., Mooi F.R., de Neeling A.J., Overbeek B.P. Isolation and characterization of a ciprofloxacin-resistant isolate of Haemophilus influenzae from the Netherlands. J Antimicrob Chemother 1997, 39:292-293.
11. Vila J., Ruiz J., Sanchez F., et al. Increase in quinolone resistance in a Haemophilus influenzae strain isolated from a patient with recurrent respiratory infections treated with ofloxacin. Antimicrob Agents Chemother 1999, 3:161-162.
12. Ho P.L., Chow K.H., Mak G.C., et al. Decreased levofloxacin susceptibility in Haemophilus influenzae in children, Hong Kong. Emerg Infect Dis 2004, 10:1960-1962.
13. Pérez-Vázquez M., Román F., Aracil B., Cantón R., Campos J. Laboratory detection of Haemophilus influenzae with decreased susceptibility to nalidixic acid, ciprofloxacin, levofloxacin, and moxifloxacin due to gyrA and parC mutations. J Clin Microbiol 2004, 42:1185-1191.
14. Nazir J., Urban C., Mariano N., et al. Quinolone-resistant Haemophilus influenzae in a long-term care facility: clinical and molecular epidemiology. Clin Infect Dis 2004, 38:1564-1569.
15. Jean S.S., Hsueh P.R., Lee W.S., et al. Nationwide surveillance of antimicrobial resistance among Haemophilus influenzae and Streptococcus pneumoniae in intensive care units in Taiwan. Eur J Clin Microbiol Infect Dis 2009, 28:1013-1017.
16. Mahoney F.I., Barthel D.W. Functional evaluation: the Barthel Index. Maryland State Med J 1965, 14:61-65.
17. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987, 40:373-383.
18. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. M07-A8. Approved standard 2008, CLSI, Wayne, PA. 8th ed.
19. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. 18th informational supplement. CLSI document. M100-S18 2008, CLSI, Wayne, PA.
20. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
21. Deguchi T., Kawamura T., Yasuda M., et al. In vivo selection of Klebsiella pneumoniae strains with enhanced quinolone resistance during fluoroquinolone treatment of urinary tract infections. Antimicrob Agents Chemother 1997, 41:1609-1611.
22. Galanakis N., Giamarellou H., Moussas T., Dounis E. Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 1997, 39:241-246.
23. Hakanen A., Kotilainen P., Jalava J., Siitonen A., Huovinen P. Detection of decreased fluoroquinolone susceptibility in Salmonellas and validation of nalidixic acid screening test. J Clin Microbiol 1999, 37:3572-3577.
24. Ho P.L., Yung R.W., Tsang D.N., et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother 2001, 48:659-665.
25. Chiu C.H., Wu T.L., Su L.H., et al. The emergence in Taiwan of fluoroquinolone resistance in Salmonella enterica serotype Choleraesuis. N Engl J Med 2002, 346:413-419.
26. Campos J., Román F., Georgiou M., et al. Long-term persistence of ciprofloxacin-resistant Haemophilus influenzae in patients with cystic fibrosis. J Infect Dis 1996, 174:1345-1347.
27. Groeneveld K., van Alphen L., Eijk P.P., Visschers G., Jansen H.M., Zanen H.C. Endogenous and exogenous reinfections by Haemophilus influenzae in patients with chronic obstructive pulmonary disease: the effect of antibiotic treatment on persistence. J Infect Dis 1990, 161:512-517.
28. Bastida T., Pérez-Vázquez M., Campos J., et al. Levofloxacin treatment failure in Haemophilus influenzae pneumonia. Emerg Infect Dis 2003, 9:1475-1478.